je.st
news
Tag: hiv
Gilead's new HIV drug shows lower side-effects over longer term
2015-10-22 16:09:33| Biotech - Topix.net
Drugmaker Gilead Sciences Inc said data from a late-stage study showed that its experimental drug, Genvoya, showed reduced side-effects compared with an older version of the drug in treating HIV-infected patients over a longer term. The company said Genvoya was as good as Stribild, which is the older version, after 96 weeks of treatment and had lesser side-effects on patients' kidneys and bones.
Scientists record HIV moving through a living body
2015-10-02 15:46:40| Extremetech
Using a cutting-edge imaging technique, scientists were able to watch the progress of an HIV infection in a living mouse.
Tags: body
record
living
moving
VIDEO: HIV drugs price hike defended
2015-09-22 11:42:56| BBC News | Business | UK Edition
The head of a US drugs company has defended his company's decision to raise the price of medication used by Aids patients by over 5,000%.
Gilead combo HIV pill matches Truvada efficacy but safer in trial
2015-09-02 18:18:32| Biotech - Topix.net
REUTERS: Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function. The company has already sought U.S. and European marketing approval for the new combo pill nicknamed F/TAF, which is meant to be a safer replacement for Truvada, a cornerstone of HIV treatment that has been associated with slight declines in bone mineral density and kidney function.
First Self-Injectable HIV Antibody: 98% Success Rate In Phase 2b Clinical Trial, Could Be Commercial In 2017
2015-08-19 07:01:19| drugdiscoveryonline Home Page
The first self-injectable antibody, PRO 140, has documented an impressive 98% success rate in a Phase 2b clinical trial for patients with HIV. In a monotherapy study, some HIV patients using PRO 140 are experiencing a completely suppressed viral load for 11 months.
Tags: in
rate
commercial
trial
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »